HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Yoji Nagashima Selected Research

Liver Cirrhosis (Hepatic Cirrhosis)

10/2021Protective effect of SGL5213, a potent intestinal sodium-glucose cotransporter 1 inhibitor, in nonalcoholic fatty liver disease in mice.
4/2015Deficiency of iNOS-derived NO accelerates lipid accumulation-independent liver fibrosis in non-alcoholic steatohepatitis mouse model.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Yoji Nagashima Research Topics

Disease

120Neoplasms (Cancer)
03/2024 - 02/2002
49Renal Cell Carcinoma (Grawitz Tumor)
03/2024 - 05/2002
25Neoplasm Metastasis (Metastasis)
03/2024 - 04/2002
18Carcinoma (Carcinomatosis)
01/2024 - 09/2004
12Inflammation (Inflammations)
12/2023 - 03/2005
12Carcinogenesis
08/2021 - 05/2002
10Prostatic Neoplasms (Prostate Cancer)
11/2012 - 02/2002
9Kidney Neoplasms (Kidney Cancer)
01/2023 - 04/2005
8Fibrosis (Cirrhosis)
01/2022 - 11/2002
8Pancreatic Neoplasms (Pancreatic Cancer)
09/2017 - 04/2002
7Chronic Kidney Failure (Chronic Renal Failure)
10/2023 - 12/2002
7Non-alcoholic Fatty Liver Disease
01/2023 - 09/2009
6Stomach Neoplasms (Stomach Cancer)
01/2023 - 02/2002
6Lung Neoplasms (Lung Cancer)
01/2018 - 04/2002
6Colorectal Neoplasms (Colorectal Cancer)
11/2014 - 03/2002
5Melanoma (Melanoma, Malignant)
12/2023 - 04/2002
5Insulin Resistance
01/2023 - 11/2008
5Breast Neoplasms (Breast Cancer)
07/2022 - 06/2008
5Infections
01/2020 - 01/2005
5Adenoma (Adenomas)
01/2020 - 02/2011
5Liver Failure
06/2009 - 01/2005
4Lymphatic Metastasis
01/2023 - 09/2004
4Glomerulonephritis
01/2023 - 07/2015
4Colonic Neoplasms (Colon Cancer)
12/2021 - 04/2002
4Disease Progression
10/2020 - 01/2006
4Alcoholic Fatty Liver
02/2017 - 04/2015
4Adenocarcinoma
01/2013 - 06/2002
3Hereditary leiomyomatosis and renal cell cancer
03/2024 - 12/2020
3Thrombosis (Thrombus)
03/2024 - 01/2017
3Squamous Cell Carcinoma (Epidermoid Carcinoma)
12/2023 - 04/2002
3Cysts
12/2023 - 04/2012
3Wilms Tumor (Wilm's Tumor)
11/2023 - 01/2013
3Hemorrhage
10/2023 - 08/2011
3Liver Diseases (Liver Disease)
01/2023 - 01/2017
3Obesity
01/2023 - 01/2017
3Tuberous Sclerosis (Bourneville's Disease)
01/2020 - 01/2009
3Angiomyolipoma
01/2020 - 01/2009
3Hypoxia (Hypoxemia)
06/2018 - 02/2005
3Body Weight (Weight, Body)
02/2016 - 01/2002
3Hypertension (High Blood Pressure)
01/2013 - 08/2011
3Pruritus (Itching)
09/2012 - 12/2008
2Leiomyoma (Uterine Fibroids)
03/2024 - 08/2015

Drug/Important Bio-Agent (IBA)

31Proteins (Proteins, Gene)FDA Link
07/2021 - 01/2002
14Messenger RNA (mRNA)IBA
12/2023 - 11/2003
10Biomarkers (Surrogate Marker)IBA
12/2023 - 02/2005
9LipidsIBA
01/2020 - 02/2005
8Semaphorin-3AIBA
07/2016 - 12/2008
7Fumarate Hydratase (Fumarase)IBA
03/2024 - 01/2018
6Hormones (Hormone)IBA
01/2023 - 02/2002
6PKC-3 proteinIBA
11/2018 - 09/2009
6ConnexinsIBA
08/2009 - 07/2004
6Heme Oxygenase-1IBA
08/2008 - 01/2002
5CreatinineIBA
12/2023 - 01/2002
5Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
10/2020 - 02/2002
4Immune Checkpoint InhibitorsIBA
12/2023 - 11/2018
4Microphthalmia-Associated Transcription FactorIBA
11/2023 - 01/2009
4Cisplatin (Platino)FDA LinkGeneric
03/2023 - 07/2005
4NivolumabIBA
01/2023 - 11/2018
4LeptinIBA
01/2023 - 02/2011
4EnzymesIBA
01/2023 - 09/2016
4VimentinIBA
01/2023 - 06/2008
4Transcription Factors (Transcription Factor)IBA
11/2021 - 10/2008
4Axitinib (AG 013736)IBA
04/2021 - 01/2017
4TOR Serine-Threonine KinasesIBA
10/2020 - 11/2008
4AntibodiesIBA
11/2019 - 09/2008
4Keratins (Keratin)IBA
07/2019 - 09/2008
4Cadherins (E-Cadherin)IBA
09/2016 - 09/2008
4LigandsIBA
11/2011 - 11/2007
4CytokinesIBA
11/2010 - 11/2002
4Gap Junction beta-1 ProteinIBA
06/2008 - 07/2004
3Prednisolone (Predate)FDA LinkGeneric
08/2023 - 10/2021
3GemcitabineFDA Link
03/2023 - 07/2006
3Mucin-1 (CA 15-3 Antigen)IBA
01/2023 - 01/2009
3Immunoglobulin G (IgG)IBA
01/2023 - 07/2016
3Glucose (Dextrose)FDA LinkGeneric
01/2023 - 02/2016
3Small Interfering RNA (siRNA)IBA
07/2022 - 04/2007
3Tyrosine Kinase InhibitorsIBA
06/2021 - 11/2003
3Capsules (Microcapsules)IBA
01/2021 - 08/2011
3MucinsIBA
10/2020 - 01/2015
3PhosphatidylglycerolsIBA
01/2020 - 04/2012
3trans-sodium crocetinate (crocetin)IBA
01/2020 - 01/2009
3Cathepsin KIBA
03/2019 - 01/2013
3Proliferating Cell Nuclear Antigen (PCNA)IBA
11/2008 - 01/2005
3AndrogensIBA
11/2008 - 11/2003
3Complementary DNA (cDNA)IBA
03/2005 - 11/2002
2pembrolizumabIBA
03/2024 - 03/2023

Therapy/Procedure

31Therapeutics
03/2024 - 02/2002
29Nephrectomy
03/2024 - 10/2002
8Drug Therapy (Chemotherapy)
11/2023 - 12/2010
7Hepatectomy
06/2014 - 01/2005
6Transplantation
12/2023 - 10/2006
5Immunotherapy
09/2021 - 01/2017
4Renal Dialysis (Hemodialysis)
01/2020 - 06/2008
3Adjuvant Chemotherapy
11/2023 - 04/2009
3Radiotherapy
03/2023 - 12/2010
3Molecular Targeted Therapy
11/2017 - 01/2017
3Kidney Transplantation
07/2016 - 07/2015
3Oral Administration
05/2012 - 04/2002
3Nephroureterectomy
06/2009 - 09/2008
2Aftercare (After-Treatment)
03/2024 - 02/2017